← Portfolio

Precision fermentation · Helsinki, Finland & USA

Onego Bio

Animal-free egg-white protein (Bioalbumen®) · onego.bio ↗

Uses precision fermentation to make Bioalbumen®, an egg-white protein identical to the one from hens, for food manufacturers.

Stage

Pre-launch / scale-up (step 4 of 6)

The FDA issued a GRAS 'no questions' letter in Sept 2025. It currently produces through contract manufacturers. Its flagship plant in Jefferson County, Wisconsin (2 million litres) is expected to start operating in 2028.[1] [2] [3]

Revenue

Pre-revenue

Agronomics' Q1 and Q2 2026 investor reports list it as not yet revenue-generating. It produces through contract manufacturers ahead of its own plant.[4] [5] [2]

Next Commercial supply through co-manufacturers; Wisconsin plant in 2028.

Agronomics' holding

Fair value
£11.14m 30 Jun 2026
Portfolio weight
8% 30 Jun 2026
Stake
16.9% 30 Jun 2026
Invested
£7.11m since Feb 2022
Multiple
1.57× +£4.04m
Per year
+11.9% all holdings
Last round
Series A 17 Jul 2024 · 2.2 years ago

Sources[4]

Investments
What Agronomics put in, at the sterling cost it carries
DateCostRound
22 Feb 2022£5.78m€6.9m Seed (led)[6] [7]
2 Apr 2024£1.33m€1.55m in the €37m round[8] [9]

Approvals & markets

  • Approved

    USA (FDA) · 23 Sep 2025[3] [1]

    GRAS 'no questions' letter for Bioalbumen® across a wide range of foods and beverages

HQ
Finland
Selling in
—
Cleared in
United States[3]

Timeline

  1. Corporate

    US court dismisses its patent suit against EVERY[10]

    Onego Bio sought to invalidate EVERY's US ovalbumin patent. The Delaware court found EVERY had not threatened to sue, so it ruled on neither validity nor infringement.

  2. Regulatory

    FDA 'no questions' letter on GRAS status[3] [1]

    Covers Bioalbumen® across a wide range of food and beverage uses.

  3. Facility

    Site chosen for flagship US plant[2]

    Jefferson County, Wisconsin.

  4. Funding

    €14m EIC Accelerator funding[11]

    With a new Series A investor, this took total funding to €65m.

Sources

  1. FDA affirms safety of Onego Bio's precision-fermented egg protein Prepared Foods · Sep 2025
  2. Onego Bio Chooses Jefferson County, Wisconsin for Flagship Egg Protein Manufacturing Facility Business Wire · 12 Mar 2025
  3. Onego Bio receives FDA 'no questions' letter on GRAS status of Bioalbumen Agronomics Limited (RNS) · 23 Sep 2025
  4. Q2 2026 Investor Report (portfolio at 30 June 2026) Agronomics Limited · 21 Aug 2026
  5. Q1 2026 Investor Report Agronomics Limited · 20 May 2026
  6. Agronomics Leads Onego Bio's Seed Funding Round Agronomics Limited (RNS) · 22 Feb 2022
  7. Annual Report 2022: year to 30 June 2022 Agronomics Limited · 20 Dec 2022
  8. Onego Bio Raises EUR37 Million Agronomics Limited (RNS) · 2 Apr 2024
  9. Annual Report 2024: year to 30 June 2024 Agronomics Limited · 24 Dec 2024
  10. Onego Bio's Patent Challenge Against EVERY Dismissed in Delaware vegconomist · 13 Oct 2026
  11. Onego Bio secures €14m in new funding Agronomics Limited (RNS) · 18 Jul 2024